There are 2,105 papers on diastolic blood pressure in aging research: 525 trials and 1,202 observational studies in people, 23 in animals, 312 reviews.
2,105 papers study it1,018 more mention it513 findings
333 new papers in 30 daysSee all 3,123 papers on diastolic blood pressure
“while load showed the strongest association (1.23, 95% CI 1.12-1.36)”
- Human trial525
- Humans1,202
- Animals23
- In silico27
Interventions
180Exercise
downin humans12no changein humans1−3.1%
13 studies
Exercise
downin humans12no changein humans1−3.1%
Exercise decreases diastolic blood pressure in humans (-2.4 mmHg (95% CI: 0.53-3.27)).
“2.4 mmHg (95% CI: 0.53-3.27), and 2.5 points (95% CI: 1.87-4.67), respectively, while BMI did not change significantly.”
Human trial12 weeks
Acta psychologica
Exercise decreases diastolic blood pressure in humans (−4.4 mmHg, 95% CI −7.2 to −1.6).
“Supportive secondary analyses, for which p values were nominal and not adjusted for multiplicity, yielded adjusted between-group differences in DBP (−4.4 mmHg, 95% CI −7.2 to −1.6; p = 0.004), resting heart rate (−4.5 beats/min, 95% CI −6.8 to −2.2; p = 0.001), and LnRMSSD (+0.31, 95% CI 0.12 to 0.50; p = 0.002”
Human trial12 weeksfemalesn = 46
Baguazhang lowers systolic blood pressure in postmenopausal women
Frontiers in physiology
Exercise decreases diastolic blood pressure in humans (-4.4 mmHg).
“adjusted differences in DBP (-4.4 mmHg), resting heart rate (-4.5 beats/min), and LnRMSSD (+0.31)”
Human trial12 weeksfemalesn = 46
Baguazhang lowers systolic blood pressure in postmenopausal women
Frontiers in physiology
Exercise decreases diastolic blood pressure in humans (-4.20 mmHg, 95% CrI: -6.52, -1.74).
“For DBP, a significant reduction was observed from 140 METs-min/week, with the quadratic model estimating the largest reduction at 1,500 METs-min/week (−4.20 mmHg, 95% CrI: −6.52, −1.74).”
Human trial1,500 METs-min/week6 to 44 weeksfemalesn = 3,573
Frontiers in medicine
Exercise decreases diastolic blood pressure in humans (P < .05).
“diastolic blood pressure, and heart rate significantly decreased in the exercise group compared to the control group (P < .05)”
Human trial12 weeksfemalesn = 36
Medicine
Exercise showed no clear effect on diastolic blood pressure in humans (hypertensive older adults) (mean difference = 2.17 mmHg, p = 0.398).
“does not have a significant effect on diastolic blood pressure”
Human trialhypertensive older adultstwo-weekn = 12
SENAM LANSIA DAN TEKANAN DARAH PADA LANSIA HIPERTENSI
Klabat Journal of Nursing
Exercise decreases diastolic blood pressure in humans (−3.1%).
“DBP also showed a significant reduction (−3.1%) following MCET, with effect sizes indicating small changes.”
Human trialone yearn = 78
Journal of clinical medicine
Exercise decreases diastolic blood pressure in humans (P+Ex: -4.0 vs. P+NEx: +0.7 mmHg, p = .032).
“Night-time DBP was lower with exercise (P+Ex: -4.0 vs. P+NEx: +0.7 mmHg, p = .032).”
Human trial12 weeksmales
Clinical endocrinology
Exercise decreases diastolic blood pressure in humans (overweight or obese older women).
“The Exercise group had significantly decreased body mass, BMI, fat mass, visceral trunk fat, and diastolic blood pressure.”
Human trialoverweight or obese older womenaerobic training at individualized maximal fat oxidation intensitythree days/week for one hour/day12 weeksfemalesn = 30
Journal of sports science & medicine
Exercise decreases diastolic blood pressure in humans.
“DBP was reduced more among exercisers.”
Human trial6 months
Exercise and risk factors associated with metabolic syndrome in older adults
American journal of preventive medicine
All 14Fewer
Resistance training
downin humans10no changein humans1
11 studies
Resistance training
downin humans10no changein humans1
Resistance training decreases diastolic blood pressure in humans (single session morning group) (p = .001).
“DBP shows statistical significant reduction in morning group ( p = .001).”
Human trialsingle session morning groupself-body weightsingle sessionfemales
Bulletin of Faculty of Physical Therapy
Resistance training decreases diastolic blood pressure in humans (-4.2 mmHg; 95% CI -8.3, -0.1).
“Compared with control, PRT produced greater reductions for DBP (difference in change, -4.2 mmHg; 95% CI -8.3, -0.1)”
Human trial12 weeksn = 71
Impact of resistance training for lowering blood pressure in older adults
American journal of preventive cardiology
Resistance training decreases diastolic blood pressure in humans (blood flow restriction and classical resistance training compared).
“Both CT and BRFT decreased diastolic blood pressure and resting heart rate”
Human trialblood flow restriction and classical resistance training comparedthrice weekly12 weeksn = 10
Blood-Flow Restriction Resistance Training Improves Muscle Mitochondrial Function in Type 2 Diabetes
ADA Scientific Sessions 2025 abstract
Resistance training decreases diastolic blood pressure in young adults who were overweight or had obesity.
“We found that RT intervention independently and in combination with TRE significantly (p < 0.05) decreased diastolic blood pressure, with values of −5.5 ± 1.9 and −4.1 ± 1.5 mmHg, respectively.”
Human trialin young adults who were overweight or had obesityeight weeksn = 15
Journal of the International Society of Sports Nutrition
Resistance training decreases diastolic blood pressure in humans (-5.5 ± 1.9 mmHg).
“In addition, RT with or without TRE notably decreased diastolic blood pressure (RT: -5.5 ± 1.9 mmHg, TRE+RT: -4.1 ± 1.5 mmHg, p < 0.05).”
Human trial8-week
Journal of the International Society of Sports Nutrition
Resistance training decreases diastolic blood pressure in humans (hypertensive) (Δ = -6.3 mmHg, dz = 0.6).
“There was an important clinical decrease in PP (Δ = -7.8 mmHg; dz = 0.7) and in DBP (Δ = -6.3 mmHg; dz = 0.6) favoring the exercise session”
Human trialhypertensiven = 18
Blood pressure monitoring
Resistance training decreases diastolic blood pressure in humans after finishing 3, 6, and 9 sets.
“Regarding the DBP, trivial, moderate, and small significant hypotensive effects were observed immediately after finishing 3, 6, and 9 sets.”
Human trialafter finishing 3, 6, and 9 sets3 to 9 sets of 20 RMn = 19
International journal of environmental research and public health
Resistance training decreases diastolic blood pressure in elderly subjects with hypertension (p < 0.05).
“in the DBP at 30 min after exercise (p < 0.05)”
Human trialin elderly subjects with hypertensionsix and nine sets of 20 RMacute (30 min)n = 19
International journal of environmental research and public health
Resistance training decreases diastolic blood pressure in humans (high-intensity) (−3.2 mmHg (−4.2%) vs −3.9 mmHg (−4.6%)).
“Although the LEX group had a decrease in supine diastolic BP (−3.9 mmHg (−4.6%)) after training, the change in supine diastolic BP was significant only for the HEX group (−3.2 mmHg (−4.2%)) (p < 0.05).”
Human trialhigh-intensity24 weeksn = 15
International journal of environmental research and public health
Resistance training decreases diastolic blood pressure in humans (-3.2 mmHg (-4.2%)).
“The HEX group showed decreases in resting heart rate (-4.0%), diastolic blood pressure (-3.2 mmHg (-4.2%)), and low frequency/high frequency (LF/HF) (Ln ratio) (p < 0.05).”
Human trial80% 1-RM24 weeksn = 40
International journal of environmental research and public health
All 14Fewer
Magnesium
downin humans6
6 studies
Magnesium
downin humans6
Magnesium decreases diastolic blood pressure in humans (ES -1.40 mmHg (95% CI -2.04 to -0.75)).
“and DBP (ES = -1.40 mmHg; 95% CI: -2.04, -0.75, P = 0.000) by magnesium supplementation”
Human trialn = 8,610
Current therapeutic research, clinical and experimental
Magnesium decreases diastolic blood pressure in humans.
“However, chronic intervention showed a decrease in DBP for post bench press on the recovery day 2.”
Human trialn = 7
Journal of the International Society of Sports Nutrition
Magnesium decreases diastolic blood pressure in humans (p = 0.047).
“Diastolic blood pressure (DBP) showed significant decreases on day 2 solely for A (p = 0.047) with no changes in the Chr.”
Human trial300 mg/d1 weekn = 13
Journal of the International Society of Sports Nutrition
Magnesium decreases diastolic blood pressure in humans (compared with placebo) (-2.05 mm Hg (95% CI, -3.23 to -0.88)).
“and diastolic BP by -2.05 mm Hg (95% CI, -3.23 to -0.88) compared with placebo”
Reviewcompared with placeboelemental
Hypertension (Dallas, Tex. : 1979)
Magnesium decreases diastolic blood pressure in humans (-10.9 mmHg, 95% CI -8.73 to -13.1, Cohen's d = 1.19).
“showed a mean change in DBP of -10.9 mmHg [95% CI=-8.73 to -13.1], p<0.0001”
Reviewin hypertensive subjects on anti-hypertensive medication continuously for at least six months with starting SBP > 155 mmHgoralat least six monthsn = 135
Magnesium research
Magnesium decreases diastolic blood pressure in humans (decrease in DBP of 2-3 mm Hg, Hedges G 0.36 (95% CI 0.27-0.44)).
“Combining all data, an overall effect of 0.36 and 0.32 for DBP and SBP, respectively, was observed (95% CI 0.27-0.44 for DBP and 0.23-0.41 for SBP)”
Review120-973 mg3 to 24 weeksn = 1,173
Effect of magnesium supplementation on blood pressure: a meta-analysis
European journal of clinical nutrition
Magnesium decreases diastolic blood pressure in humans (pooled random-effects meta-analysis of RCTs versus placebo, no treatment or usual care) (mean difference -2.2 mmHg, 95% CI -3.4 to -0.9).
“but did statistically significantly reduce DBP (mean difference: -2.2 mmHg, 95% CI: -3.4 to -0.9, I(2)=47%)”
Reviewpooled random-effects meta-analysis of RCTs versus placebo, no treatment or usual careeight to 26 weeks follow-upn = 545
Magnesium supplementation for the management of essential hypertension in adults
The Cochrane database of systematic reviews
Curcumin
downin humans3no changein humans2
5 studies
Curcumin
downin humans3no changein humans2
Curcumin showed no clear effect on diastolic blood pressure in adults with prediabetes or T2D (WMD -1.20 mmHg (95% CI -2.84 to 0.44)).
“However, no significant effect was found on DBP (WMD: -1.20 mmHg; 95% CI: -2.84 to 0.44; p = 0.15; I2 = 84.3%).”
Reviewin adults with prediabetes or T2Dn = 855
Endocrinology, diabetes & metabolism
Curcumin decreases diastolic blood pressure in postmenopausal women (SMD -0.63, 95% CI -0.96 to -0.30, p = 0.005).
“diastolic blood pressure (SMD -0.63, 95% CI -0.96 to -0.30, p = 0.005)”
Reviewin postmenopausal womenfemalesn = 982
Effects of Curcumin on Postmenopausal Women's Health: A Systematic Review and Meta-Analysis
Phytotherapy research : PTR
Curcumin decreases diastolic blood pressure in humans (metabolic disorders) (WMD = -0.94, 95 % CI: -1.59, -0.30).
“curcumin decreased diastolic blood pressure (DBP) [WMD = -0.94, 95 % CI: -1.59, -0.30; p = 0.004]”
Reviewmetabolic disorders
Prostaglandins & other lipid mediators
Curcumin showed no clear effect on diastolic blood pressure in humans (0.28 mmHg, 95% CI -1.12 to 1.68).
“and DBP (0.28 mmHg; 95% CI: -1.12, 1.68; I2 = 53%).”
Review
The effect of Curcumin/Turmeric on blood pressure modulation: A systematic review and meta-analysis
Pharmacological research
Curcumin decreases diastolic blood pressure in patients with metabolic syndrome (p = 0.007).
“The results showed significant improvement of fasting blood glucose (p = 0.01), triglycerides (p < 0.001), high-density lipoprotein cholesterol (p = 0.003), and diastolic blood pressure (p = 0.007) levels.”
Reviewin patients with metabolic syndrome
Phytotherapy research : PTR
Vitamin D
no changein humans3upin humans1downin humans1−3.2%
5 studies
Vitamin D
no changein humans3upin humans1downin humans1−3.2%
Vitamin D showed no clear effect on diastolic blood pressure in patients with essential hypertension.
“Vitamin D supplementation may significantly reduce SBP and MAP but not DBP in patients with essential hypertension.”
Human trialin patients with essential hypertension8 weeksn = 173
Advances in experimental medicine and biology
Vitamin D decreases diastolic blood pressure in humans (-3.2%).
“mean diastolic BP by 3.2% (P = 0.0419).”
Human trial60,000 IU8 weeksfemalesn = 290
Indian journal of public health
Vitamin D showed no clear effect on diastolic blood pressure in humans (hypertension and hypovitaminosis D).
“The data showed that Vitamin D significantly decreased SBP levels; however, it did not affect DBP levels.”
Reviewhypertension and hypovitaminosis D
Journal of hypertension
Vitamin D improves diastolic blood pressure in humans (ESWMD = -0.66 mm Hg; 95% CI, -1.05 to -0.27 [P < 0.001]).
“vitamin D supplementation indicated a significant improvement in diastolic blood pressure based on WMD effect sizes”
Review
Clinical therapeutics
Vitamin D showed no clear effect on diastolic blood pressure in humans (normotensive or hypertensive populations) (WMD -0.02, 95% CI -4.04 to 4.01).
“but not diastolic blood pressure (DBP) (WMD: -0.02, 95% CI: -4.04, 4.01) compared with calcium or placebo.”
Reviewnormotensive or hypertensive populationsn = 429
Effects of vitamin D supplementation on blood pressure
Southern medical journal
Quercetin
downin humans3no changein humans1no changein reviews1
5 studies
Quercetin
downin humans3no changein humans1no changein reviews1
Quercetin showed no clear effect on diastolic blood pressure.
“The results indicated Quercetin does not affect diastolic blood pressure (DBP), lipid profile, inflammation, anthropometric indices, fasting plasma glucose (FBG), and homeostatic model assessment for insulin resistance (HOMA-IR).”
Review
Phytotherapy research : PTR
Quercetin decreases diastolic blood pressure in humans ((pre)hypertensive subgroup) (MD: -3.14mmHg; 95% CI: -4.44 - -1.84; P < 0.00001).
“DBP in the (pre)hypertensive subgroup (MD: -3.14mmHg; 95% CI: -4.44 - -1.84; P < 0.00001)”
Review(pre)hypertensive subgroup
The Effects of Quercetin Supplementation on Blood Pressure - Meta-Analysis
Current problems in cardiology
Quercetin decreases diastolic blood pressure in humans (WMD -2.86 mmHg, 95% CI -5.09 to -0.63).
“and diastolic BP (WMD, -2.86 mmHg; 95%CI, -5.09 to -0.63; P = 0.01).”
Review
Nutrition reviews
Quercetin showed no clear effect on diastolic blood pressure in patients with metabolic syndrome and related disorders (WMD -3.14, 95% CI -8.24 to 1.95).
“quercetin supplementation did not significantly affect diastolic blood pressure (DBP) (WMD: -3.14; 95% CI: -8.24, 1.95)”
Reviewin patients with metabolic syndrome and related disorders
Current pharmaceutical design
Quercetin decreases diastolic blood pressure in humans (WMD -2.63 mm Hg, 95% CI -3.26 to -2.01, P<0.001).
“diastolic BP (WMD: -2.63 mm Hg, 95% CI: -3.26, -2.01, P<0.001) following supplementation with quercetin.”
Reviewn = 587
Journal of the American Heart Association
Sauna
downin humans4
4 studies
Sauna
downin humans4
Sauna decreases diastolic blood pressure in humans.
“Diastolic blood pressure was significantly lower in the first heating session compared to the measurement before entering the sauna (p < 0.05).”
Human triala single sauna session, during which they entered the sauna room three times for 10 minfemalesn = 28
Scientific reports
Sauna decreases diastolic blood pressure in humans (temperature of 80°C and 120°C).
“The mean values of SBP and DBP decreased significantly during 20 min sauna sessions with a temperature of 80°C (p < 0.001 and p = 0.015, respectively) and 120°C (excluding SBP, p < 0.001).”
Human trialtemperature of 80°C and 120°Cblood26 minfemalesn = 22
Frontiers in public health
Sauna decreases diastolic blood pressure in humans (p < 0.001).
“Twenty-minute sauna sessions with a temperature of 80°C and 120°C induced a significant (p < 0.001) decrease in the values of SBP (excluding the temperature of 120°C), DBP, and body mass”
Human trial20 minfemalesn = 22
Frontiers in public health
Sauna decreases diastolic blood pressure in humans.
“DBP and MAP were significantly lower for SAUNA.”
Human trial30 minutesn = 72
Health science reports
Sauna decreases diastolic blood pressure in humans (cardiovascular risk factors) (mean difference 2.5 [1.0, 4.1], P = .002).
“From PRE-POST, SAUNA had lower DBP (mean difference [95% CI] 2.5 [1.0, 4.1], P = .002)”
Human trialcardiovascular risk factorsn = 72
Health science reports
Sauna decreases diastolic blood pressure in humans (at least one cardiovascular risk factor) (82 to 75 mm Hg).
“After a single sauna session, diastolic blood pressure decreased from 82 to 75 mm Hg”
Human trialat least one cardiovascular risk factor30 minn = 102
European journal of preventive cardiology
Coenzyme Q10
downin humans3no changein humans1
4 studies
Coenzyme Q10
downin humans3no changein humans1
Coenzyme Q10 decreases diastolic blood pressure in humans (−2.2 ± 0.5 mmHg, P < 0.001).
“Fenofibrate (−1.3 ± 0.5 mmHg, P = 0.013) and CoQ (−2.2 ± 0.5 mmHg, P < 0.001) had independent effects in lowering 24-h diastolic BP (DBP): fenofibrate lowered asleep DBP (−2.6 ± 0.9, P = 0.005), whereas CoQ lowered awake DBP (−2.7 ± 0.6, P < 0.001).”
Human trial6 months
Diabetes care
Coenzyme Q10 decreases diastolic blood pressure in type 2 diabetic subjects with left ventricular diastolic dysfunction (-2.2 +/- 0.5 mmHg, P < 0.001).
“Fenofibrate (-1.3 +/- 0.5 mmHg, P = 0.013) and CoQ (-2.2 +/- 0.5 mmHg, P < 0.001) independently lowered 24-h diastolic blood pressure.”
Human trialin type 2 diabetic subjects with left ventricular diastolic dysfunction200 mg daily6 months
Diabetes care
Coenzyme Q10 decreases diastolic blood pressure in humans (essential hypertension) (p less than 0.05 to p less than 0.001).
“Four patients receiving CoQ10 for 3-5 months showed reductions (p less than 0.05 to p less than 0.001) of diastolic pressure”
Human trialessential hypertension3-5 monthsn = 4
Research communications in chemical pathology and pharmacology
Coenzyme Q10 showed no clear effect on diastolic blood pressure in patients with metabolic diseases (SMD -0.08, 95% CI -0.46, 0.29).
“CoQ10 supplementation decreased diastolic blood pressure (DBP), but this was not statistically significant (SMD - 0.08; 95% CI - 0.46, 0.29)”
Reviewin patients with metabolic diseasesn = 684
High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension
Coenzyme Q10 decreases diastolic blood pressure in subjects with systolic BP > 140 mmHg or diastolic BP > 90 mmHg (-7 mmHg (95% CI 5, 8)).
“DBP of 7 mmHg (95% CI 5, 8)”
Reviewin subjects with systolic BP > 140 mmHg or diastolic BP > 90 mmHgn = 96
Blood pressure lowering efficacy of coenzyme Q10 for primary hypertension
The Cochrane database of systematic reviews
Combined aerobic and resistance training
downin humans4
4 studies
Combined aerobic and resistance training
downin humans4
Combined aerobic and resistance training decreases diastolic blood pressure in humans (non-Alzheimer's disease).
“reductions in systolic (p = 0.001) and diastolic (p = 0.017) blood pressure”
Human trialnon-Alzheimer's disease14 weeksfemalesn = 40
Experimental gerontology
Combined aerobic and resistance training decreases diastolic blood pressure in humans (-6 mmHg).
“diastolic BP was lower after aerobic (-5mmHg) and concurrent exercise (-6mmHg) in comparison with Control.”
Human trial45minmalesn = 20
Effects of concurrent and aerobic exercises on postexercise hypotension in elderly hypertensive men
Experimental gerontology
Combined aerobic and resistance training decreases diastolic blood pressure in humans (stage 1 hypertension).
“For diastolic blood pressure, combined aerobic-resistance training was effective in stage 1 hypertension.”
Reviewstage 1 hypertension
Life (Basel, Switzerland)
Combined aerobic and resistance training decreases diastolic blood pressure in humans (hypertension) (WMD = -5.93 mm Hg, 95% CI (-9.24, -2.61)).
“and diastolic blood pressure (DBP) [WMD = -5.93 mm Hg, 95% CI (-9.24, -2.61), Z = 3.51, P < 0.05]”
Reviewhypertension
Frontiers in cardiovascular medicine
Tai chi
downin humans3
3 studies
Tai chi
downin humans3
Tai chi decreases diastolic blood pressure in humans (compared with aerobic exercise) (8.0 mmHg lower).
“After the 12-week intervention, the SBP and DBP in the Tai Chi group was 5.50 mmHg (Z = -2.282, P = 0.022) and 8.0 mmHg (Z = -3.360, P = 0.001) lower than that in the aerobic exercise group, respectively.”
Human trialcompared with aerobic exercise12-week
BMC geriatrics
Tai chi decreases diastolic blood pressure in humans.
“Tai Chi was associated with significant reductions in systolic blood pressure, diastolic blood pressure, LDL-C, triglycerides, and total cholesterol”
Reviewfemales
Frontiers in cardiovascular medicine
Tai chi decreases diastolic blood pressure in humans (ES = -0.426, p = .001).
“diastolic blood pressure (DBP) (ES = -0.426, p = .001)”
Review
The aging male : the official journal of the International Society for the Study of the Aging Male
High-intensity interval training
downin humans3
3 studies
High-intensity interval training
downin humans3
High-intensity interval training decreases diastolic blood pressure in humans (-2.64 mmHg (95% CI -4.79 to -0.48)).
“Participants in both groups improved diastolic BP [F (1, 87.32) = 4.392, p = 0.039], with greatest effect within the HIIT group [estimated mean change (95% CI): -2.64 mmHg, (-4.79 to -0.48), p = 0.017]”
Human trialcombined with mind-motor training, in older adults with hypertension and subjective cognitive decline6 months
Frontiers in aging neuroscience
High-intensity interval training decreases diastolic blood pressure in middle-aged and elderly populations with chronic diseases (SMD = -0.23, 95% CI: -0.39 to -0.08, p < 0.01).
“HIIT significantly benefits for DBP (SMD = -0.23, 95% CI: -0.39 to -0.08, p < 0.01)”
Reviewin middle-aged and elderly populations with chronic diseasesn = 1,066
Frontiers in physiology
High-intensity interval training decreases diastolic blood pressure in humans with or without hypertension (MD -5.48, 95% CI -8.71 to -2.25, P < 0.01).
“diastolic BP (MD -5.48; 95%CI -8.71 to -2.25; P < 0.01; I2 = 40%) versus control group”
Reviewwith or without hypertension≥4 weeksn = 266
Experimental gerontology
Aerobic exercise
downin humans2no changein humans1
3 studies
Aerobic exercise
downin humans2no changein humans1
Aerobic exercise decreases diastolic blood pressure in humans (-5 mmHg).
“diastolic BP was lower after aerobic (-5mmHg) and concurrent exercise (-6mmHg) in comparison with Control.”
Human trial45minmalesn = 20
Effects of concurrent and aerobic exercises on postexercise hypotension in elderly hypertensive men
Experimental gerontology
Aerobic exercise decreases diastolic blood pressure in humans (hypertension) (SMD = -0.48, 95% CI = -0.75 to -0.21, P =0.001).
“diastolic blood pressure (SMD = -0.48, 95% CI = -0.75 to -0.21, P =0.001)”
Reviewhypertension
International journal of general medicine
Aerobic exercise showed no clear effect on diastolic blood pressure in humans (MD = -1.4096, 95% CI (-8.2395, 5.4201), P > 0.05).
“For diastolic blood pressure (DBP), aerobic exercise interventions [MD = -1.4096; P > 0.05, 95% CI (-8.2395, 5.4201)] and static exercise interventions [MD = -4.5206, P > 0.05, 95% CI (-14.0436, 5.0023)] were not statistically significant.”
Review
Frontiers in public health
Cholecalciferol
no changein humans3
3 studies
Cholecalciferol
no changein humans3
Cholecalciferol showed no clear effect on diastolic blood pressure in humans (high-dose vs low-dose) (0.3 mm Hg).
“The reduction was 3.02 (12.1) mm Hg in the high-dose arm (P =.01) and a 2.6 (12.1) mm Hg reduction in the low-dose arm (P =.089); the differences between the 2 vitamin D arms was 0.3 mm Hg (P =.838).”
Human trialhigh-dose vs low-dose1-yearn = 257
Blood Pressure Decreases in Overweight Elderly Individuals on Vitamin D: A Randomized Trial
Journal of the Endocrine Society
Cholecalciferol showed no clear effect on diastolic blood pressure in humans (healthy adults without severe vitamin D deficiency) (0.5 (-1.1, 2.2) mm Hg, P=0.53).
“0.5 (-1.1, 2.2) mm Hg for diastolic (P=0.53)”
Human trialhealthy adults without severe vitamin D deficiency200 000 IU for 2 months followed by 100 000 IU monthly18 months
Hypertension (Dallas, Tex. : 1979)
Cholecalciferol showed no clear effect on diastolic blood pressure in humans (P=0.37).
“There was no effect of cholecalciferol supplementation on diastolic pressure (P=0.37).”
Human trial3 monthsn = 250
Effect of vitamin D supplementation on blood pressure in blacks
Hypertension (Dallas, Tex. : 1979)
Heat therapy
downin humans2
2 studies
Heat therapy
downin humans2
Heat therapy decreases diastolic blood pressure in humans (acute post-treatment during home sessions) (5 mmHg vs no change).
“On average, systolic and diastolic BP decreased by ~7 and 5 mmHg, respectively, by the end of the treatment in the HT group, while no changes were observed in the SHAM group.”
Human trialacute post-treatment during home sessions12 weeksn = 24
Journal of applied physiology (Bethesda, Md. : 1985)
Heat therapy decreases diastolic blood pressure in humans (-6.8 mmHg).
“Similarly, diastolic blood pressure significantly decreased from pre-HT to post-HT by an average of 6.8mmHg (SD = 6.9, p<0.001).”
Human trialfour weeksn = 18
Journal of applied physiology (Bethesda, Md. : 1985)
Heat therapy decreases diastolic blood pressure in humans (at risk for AD due to metabolic factors) (P < 0.05).
“significant improvements in mean arterial pressure, diastolic blood pressure, and cerebral blood flow postintervention were observed.”
Human trialat risk for AD due to metabolic factors4 wkn = 18
Journal of applied physiology (Bethesda, Md. : 1985)
Solanum lycopersicum
downin humans2−3.8%
2 studies
Solanum lycopersicum
downin humans2−3.8%
Solanum lycopersicum decreases diastolic blood pressure in humans.
“Diastolic blood pressure (DBP) decreased by 3.8% (p = 0.015).”
Human trial45-day intervention period followed by a 15-day follow-upn = 30
Frontiers in nutrition
Solanum lycopersicum decreases diastolic blood pressure in individuals with elevated cholesterol levels (-3.8%).
“the FFG exhibited significant reductions in systolic blood pressure (SBP) and diastolic blood pressure (DBP) by 4.2% (SBP, p < 0.001) and 3.8% (DBP, p = 0.015), respectively”
Human trialin individuals with elevated cholesterol levelstablets300 mg daily45-day treatment phase followed by a 15-day observational follow-upn = 60
Frontiers in nutrition
Solanum lycopersicum is linked with lower diastolic blood pressure in humans (intermediate vs. lowest consumption) (β = -0.65 mmHg [95% CI: -1.20, -0.10]).
“An inverse association between tomato consumption and diastolic blood pressure was observed between the intermediate group β = -0.65 mmHg [95% confidence interval (CI): -1.20, -0.10] and the lowest consumption group.”
Humansintermediate vs. lowest consumption44-82 g/day3-yearn = 7,056
European journal of preventive cardiology
All 180Fewer
Effects
23Mortality
no changein humans3RR 0.92
3 studies
Mortality
no changein humans3RR 0.92
Diastolic blood pressure was not clearly linked with mortality in humans ((pre)frailty).
“There were no significant differences in all-cause mortality among DBP categories.”
Humans(pre)frailtyn = 528
Frontiers in cardiovascular medicine
Diastolic blood pressure was not clearly linked with mortality in humans (brisk walkers (≥1.0 m/s)) (HR 1.05, 95% CI 0.98-1.11).
“whereas it was null in brisk walkers (hazard ratio = 1.05; 95% confidence interval: 0.98, 1.11), p value for interaction .01.”
Humansbrisk walkers (≥1.0 m/s)mean of 10 years
Blood Pressure Trajectory, Gait Speed, and Outcomes: The Health, Aging, and Body Composition Study
The journals of gerontology. Series A, Biological sciences and medical sciences
Diastolic blood pressure showed no clear effect on mortality in humans (patients with kidney failure on maintenance peritoneal dialysis) (RR, 0.92; 95% CI, 0.53-1.57).
“No association was found between diastolic BP >90 mm Hg (vs diastolic BP ≤90 mm Hg) and mortality (RR, 0.92; 95% CI, 0.53-1.57).”
Reviewpatients with kidney failure on maintenance peritoneal dialysis
Kidney medicine
Executive functioning
upin humans1downin humans1
1 study
Executive functioning
upin humans1downin humans1
Diastolic blood pressure is linked with better executive functioning in humans (slope = +0.02, p = 0.04).
“whereas in males the effect was attenuated and slightly protective (slope = +0.02, p = 0.04).”
Humans7-yearsmalesn = 800
GSA 2025 abstract
Diastolic blood pressure is linked with worse executive functioning in humans (slope=-0.06, p = 0.01).
“Among females, higher diastolic BP predicted steeper age-related decline”
Humans7-yearsfemalesn = 800
GSA 2025 abstract
Kidney failure
mediatesin humans1
1 study
Kidney failure
mediatesin humans1
Diastolic blood pressure is linked with kidney failure in humans (Mediation of the relationship between body mass index and renal failure) (6.37% mediated).
“five acted as mediators in the relationship between BMI and renal failure: cystatin C (12.34%), glucose (7.02%), glycated hemoglobin (HbA1c) (6.83%), diastolic blood pressure (6.37%)”
HumansMediation of the relationship between body mass index and renal failure
Medicine
Lacunar stroke
mediatesin humans1
1 study
Lacunar stroke
mediatesin humans1
Diastolic blood pressure is linked with lacunar stroke in humans (mediating WHRadjBMI effect on lacunar stroke) (29.2% (95% CI, 12.1%-46.3%)).
“followed by diastolic blood pressure (29.2%; 12.1%-46.3%)”
Humansmediating WHRadjBMI effect on lacunar stroke
Abdominal Adiposity and Lacunar Stroke: A Mendelian Randomization Mediation Study
medRxivPreprint
SCORE2
no changein humans1
1 study
SCORE2
no changein humans1
Diastolic blood pressure was not clearly linked with SCORE2 in humans (diastolic BP >=70 mmHg with systolic BP < 120 mmHg after adjustment for systolic BP).
“Their slightly higher SCORE2 was attributable to higher systolic BP and age, and was no longer significant after adjustment for systolic BP.”
Humansdiastolic BP >=70 mmHg with systolic BP < 120 mmHg after adjustment for systolic BPn = 1,394
Journal of hypertension
Major adverse cardiac and cerebrovascular events
no changein humans1OR 0.76
1 study
Major adverse cardiac and cerebrovascular events
no changein humans1OR 0.76
Diastolic blood pressure was not clearly linked with major adverse cardiac and cerebrovascular events in humans (OR 0.76, 95% CI 0.55–1.04).
“Below this threshold, DBP showed no association with MACCE (OR: 0.76, 95% CI: 0.55-1.04)”
HumansCoronary artery disease after percutaneous coronary intervention; baseline diastolic blood pressure below approximately 73 mm HgMean follow-up of 29.8 months
BMC cardiovascular disorders
Stroke
mediatesin humans1
1 study
Stroke
mediatesin humans1
Diastolic blood pressure is linked with stroke in humans (association of cumMETS-IR with stroke) (mediation proportion 9.6%).
“Mediation analysis revealed that DBP partially explained this association, with a mediation proportion of 9.6%.”
Humansassociation of cumMETS-IR with stroke
Cardiovascular diabetology
Retinal age gap
upin humans1
1 study
Retinal age gap
upin humans1
Diastolic blood pressure is linked with higher retinal age gap in humans (adjusting for age, sex, and ethnicity) (β = 0.052, 95% CI: 0.038-0.066, p < 0.001).
“diastolic blood pressure (β = 0.052, 95% CI: 0.038-0.066, p < 0.001)”
Humansadjusting for age, sex, and ethnicityn = 4,798
Modifiable risk factors associated with increased retinal age gap in an Australian population
GeroScience
White matter hyperintensity volume
no changein humans1
1 study
White matter hyperintensity volume
no changein humans1
Diastolic blood pressure was not clearly linked with white matter hyperintensity volume in humans.
“Diastolic blood pressure showed no significant association with white matter hyperintensity volumes.”
Humansn = 439
The Role of Elevated Midlife Blood Pressure on Cognition and White Matter Hyperintensities
AAIC 2025 abstract
Vascular-related dementia
mediatesin humans1
1 study
Vascular-related dementia
mediatesin humans1
Diastolic blood pressure is linked with vascular-related dementia in humans (Mediation of the genetic effect of body mass index) (25% mediated (95% CI, 13%–75%)).
“diastolic blood pressure mediated 25% (13%-75%) of the genetic effect of BMI on vascular-related dementia.”
HumansMediation of the genetic effect of body mass index
The Journal of clinical endocrinology and metabolism
All 23Fewer
Upstream
15Genetic risk score
upin humans1
1 study
Genetic risk score
upin humans1
Genetic risk score is linked with higher diastolic blood pressure in humans (longitudinal interaction).
“A positive longitudinal interaction was also found between the GRS and each adiposity indicator on DBP.”
Humanslongitudinal interaction
Interaction between adiposity and genetic risk score on blood pressure traits in Mexican adults
Journal of human hypertension
Menopause
downin humans1
1 study
Menopause
downin humans1
Menopause is linked with lower diastolic blood pressure in humans following menopause (b = -0.004, p < 0.001).
“SBP age trajectories were higher (b = 0.002, p < 0.001) and DBP trajectories lower (b = -0.004, p < 0.001) following menopause.”
Humansfollowing menopausefemales
American journal of biological anthropology
Periodontitis
no changein humans1
1 study
Periodontitis
no changein humans1
Periodontitis was not clearly linked with diastolic blood pressure in humans (treated hypertensive participants).
“severe periodontitis was significantly associated with uncontrolled SBP but not DBP.”
Humanstreated hypertensive participantsn = 417
Periodontitis Is Associated With Poor Blood Pressure Control in Treated Hypertensive Individuals
Journal of clinical periodontology
Body mass index
no changein humans1
1 study
Body mass index
no changein humans1
Body mass index was not clearly linked with diastolic blood pressure in humans (adults) (DBP p = 0.07, MAP p = 0.15).
“no significant differences were found in DBP (p = 0.07) or MAP (p = 0.15) across BMI categories”
Humansadultsn = 87
Research SquarePreprint
Total cholesterol
mediatesin humans1
1 study
Total cholesterol
mediatesin humans1
Total cholesterol is linked with diastolic blood pressure in humans (relationship between smoking/vaping and diastolic BP) (6.7% mediation effect).
“Mediation analysis revealed that higher total cholesterol partly mediated (6.7% mediation effect) the relationship between smoking/vaping and diastolic BP.”
Humansrelationship between smoking/vaping and diastolic BPn = 6,262
American journal of physiology. Heart and circulatory physiology
Circadian clock
downin humans1
1 study
Circadian clock
downin humans1
Circadian clock decreases diastolic blood pressure in humans (active standing at 3 min).
“Diastolic BP was also significantly reduced at 3 min (P = 0.013) in older adults.”
Human trialactive standing at 3 minn = 6
The Journal of physiology
Thiamine
no changein humans1
1 study
Thiamine
no changein humans1
Thiamine was not clearly linked with diastolic blood pressure in humans (community-based cohort).
“No significant relationship was found for diastolic BP.”
Humanscommunity-based cohortfemalesn = 2,015
Nutrients
Isovaleric acid
downin humans1
1 study
Isovaleric acid
downin humans1
Isovaleric acid is linked with lower diastolic blood pressure in humans (β = -2.11, 95% CI: -3.94 - -0.29).
“significant negative association between iso-VA (β = -2.11, 95% CI: -3.94 - -0.29) and diastolic blood pressure (DBP) levels.”
Humansserumn = 1,013
Scientific reports
Multiple sclerosis
upin humans1
1 study
Multiple sclerosis
upin humans1
Multiple sclerosis is linked with higher diastolic blood pressure in humans (older adults with MS and healthy controls).
“higher diastolic BP (DBP) than healthy controls”
Humansolder adults with MS and healthy controls
Blood pressure and cognition in older adults with multiple sclerosis: preliminary examination
Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Type 1 diabetes
downin humans1
1 study
Type 1 diabetes
downin humans1
Type 1 diabetes is linked with lower diastolic blood pressure in humans (compared with CON) (p<0.001).
“compared with CON, diastolic blood pressure was significantly lower at both time-points in the T1D group (p<0.001).”
Humanscompared with CONn = 126
Canadian journal of diabetes
Older-adults
upin humans1
1 study
Older-adults
upin humans1
Older-adults increase diastolic blood pressure in humans (Δ13 ± 2 mmHg vs Δ5 ± 2 mmHg (young) and Δ6 ± 1 mmHg (middle-aged)).
“Under PEMI, the increase in diastolic BP (DBP) from rest to RHG exercise in the older adult group (Δ13 ± 2 mmHg) was significantly higher than that in the young”
Human trialduring postexercise muscle ischemia (PEMI) following 1 min rhythmic handgrip exercise at 30% MVC
Aging exaggerates blood pressure response to ischemic rhythmic handgrip exercise in humans
Physiological reports
All 15Fewer
Associations
147Mortality
upin humans8downin humans8mixedin humans2HR 0.72–2.41
18 studies
Mortality
upin humans8downin humans8mixedin humans2HR 0.72–2.41
Diastolic blood pressure is linked with a higher risk of mortality in humans (10 mm Hg increment after MI) (HR 1.09 (95% CI: 1.04–1.15)).
“1.09 (95% CI: 1.04–1.15, P<0.001,Figure 1) for diastolic BP.”
Humans10 mm Hg increment after MImedian follow-up of 7.5 yearsn = 4,788
ESC Congress 2026 abstract
Diastolic blood pressure is associated with mortality in individuals with atrial fibrillation (RR 0.99, 0.97-1.02).
“DBP exhibited a J-shaped association, with the lowest risk at 83 mmHg (RR 0.99, 0.97-1.02).”
Humansin individuals with atrial fibrillation
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
Diastolic blood pressure predicts mortality in humans (geriatric ICU admission) (aHR 0.98, 95% CI 0.97-0.99).
“the independent predictors were diastolic blood pressure (aHR 0.98, 0.97-0.99), bicarbonate (aHR 0.96, 0.93-0.98), and Glasgow Coma Scale (aHR 0.95, 0.91-1.00)”
Humansgeriatric ICU admissionn = 265
Cureus
Diastolic blood pressure is linked with a lower risk of mortality in multivariable analysis, particularly in the VL-dia and L-dia groups.
“lower DBP, particularly in the VL-dia and L-dia groups, was associated with reduced risks.”
Humansin multivariable analysis, particularly in the VL-dia and L-dia groups
BMC nephrology
Diastolic blood pressure is associated with mortality in humans (type 2 diabetes and chronic kidney disease) (90 mmHg).
“higher DBP (90 mmHg) was linked to increased mortality”
Humanstype 2 diabetes and chronic kidney disease
Diabetes, obesity & metabolism
Diastolic blood pressure is linked with a higher risk of mortality in humans (HR=1.086, 95%CI: 1.023-1.152).
“The risk for all-cause mortality increased by 8.6% (HR=1.086, 95%CI: 1.023-1.152), and the risk for cardio-cerebrovascular mortality increased by 19.9%”
Humans
Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi
Diastolic blood pressure is linked with a lower risk of mortality in humans (history of hyperglycemia without diabetes) (OR = 0.958, P = 0.027).
“diastolic pressure (OR = 0.958, P = 0.027)”
Humanshistory of hyperglycemia without diabetes15 yearsmalesn = 220
Heliyon
Diastolic blood pressure is linked with a higher risk of mortality in humans (compared with DBP 80 mm Hg) (HR 1.33 (95% CI: 1.04-1.71)).
“Compared with a DBP of 80 mm Hg, the fully adjusted HR for mortality was 1.33 (95% confidence interval [CI]: 1.04-1.71) for a DBP of 50 mm Hg”
Humanscompared with DBP 80 mm Hg50 mm Hg5 yearsfemalesn = 7,875
American journal of hypertension
Diastolic blood pressure is associated with mortality in humans (cognitively healthy adults).
“while a significant inverse association was observed for diastolic BP.”
Humanscognitively healthy adults
Association of Cumulative Blood Pressure With Cognitive Decline, Dementia, and Mortality
Journal of the American College of Cardiology
Diastolic blood pressure is linked with a higher risk of mortality in humans (DBP <50 mmHg vs reference 70-79 mmHg) (HR 2.41 (95% CI 1.28-4.54)).
“With DBP of 70-79 mmHg as the reference, HRs were DBP <50 mmHg: 2.41 (1.28-4.54)”
HumansDBP <50 mmHg vs reference 70-79 mmHg2009 through end-December 2015n = 4,443
Journal of aging and health
All 18Fewer
Cardiovascular disease
upin humans5downin humans2no changein humans1HR 0.43–1.5
7 studies
Cardiovascular disease
upin humans5downin humans2no changein humans1HR 0.43–1.5
Diastolic blood pressure is linked with a lower risk of cardiovascular disease in humans (HR 0.43 (0.36-0.51)).
“HR 0.43 (0.36-0.51) and 0.45 (0.38-0.541) for 69 vs 89 mmHg after 10 and 20 years, respectively.”
Humans10 yearsmales
Lower teen blood pressure linked to lower cardiovascular risk
AHA Scientific Sessions 2026 abstract
Diastolic blood pressure is linked with a higher risk of cardiovascular disease in humans (10 mm Hg increment after MI) (HR 1.07 (95% CI: 1.03–1.12)).
“1.07 (95% CI: 1.03–1.12, P=0.001,Figure 1) for diastolic BP.”
Humans10 mm Hg increment after MImedian follow-up of 7.5 yearsn = 4,788
ESC Congress 2026 abstract
Diastolic blood pressure is linked with a higher risk of cardiovascular disease in humans (HR 1.20, 95% CI 1.09-1.31 per 5 mm Hg higher diastolic BP).
“The adjusted hazard ratio (HR) (95% confidence interval) for CVD events per 10 mm Hg higher systolic and 5 mm Hg higher diastolic BP was 1.22 (1.04-1.42) and 1.20 (1.09-1.31), respectively.”
Humans24 yearsn = 5,933
Blood pressure and cardiovascular risk in a contemporary cohort of young adults
American journal of hypertension
Diastolic blood pressure is linked with a higher risk of cardiovascular disease in humans (HR, 1.19; 95 % CI, 1.12 to 1.26).
“For each SD increase, DBP was associated with elevated CVD events for both <50 year (HR, 1.19; 95 % CI, 1.12 to 1.26)”
Humans
Experimental gerontology
Diastolic blood pressure is linked with a higher risk of cardiovascular disease in humans (compared with DBP 80 mm Hg) (HR 1.50 (95% CI: 1.03-2.17)).
“HR 1.50 (95% CI: 1.03-2.17) for a DBP of 100 mm Hg”
Humanscompared with DBP 80 mm Hg100 mm Hg5 yearsfemalesn = 7,875
American journal of hypertension
Diastolic blood pressure is associated with cardiovascular disease in humans (compared with DBP 80 mm Hg) (HR 1.14 (95% CI: 0.78-1.67)).
“The HRs for CVD were 1.14 (95% CI: 0.78-1.67) for a DBP of 50 mm Hg”
Humanscompared with DBP 80 mm Hg50 mm Hg5 yearsfemalesn = 7,875
American journal of hypertension
Diastolic blood pressure is linked with a higher risk of cardiovascular disease in humans (OR 1.91, 95% CI 1.73, 2.11).
“and OR 1.91, 95% CI 1.73, 2.11, respectively).”
Humans
Scientific reports
Diastolic blood pressure is linked with a lower risk of cardiovascular disease in those with ADL limitation, DBP 66 to 80 mm Hg compared with DBP ≤65 (HR 0.65 (95% CI 0.44–0.96)).
“Among those with ADL limitation, DBP was inversely associated with CVD: HR 0.65 (0.44, 0.96) for DBP 66 to 80 mm Hg and HR 0.49 (0.25, 0.94) for DBP >80, compared with DBP ≤65.”
Humansin those with ADL limitation, DBP 66 to 80 mm Hg compared with DBP ≤659 yearsn = 2,358
Hypertension (Dallas, Tex. : 1979)
Cognitive function
upin humans3downin humans1mixedin humans1
5 studies
Cognitive function
upin humans3downin humans1mixedin humans1
Diastolic blood pressure is associated with cognitive function in humans (P < .05).
“decreases in diastolic BP over time were associated with later decreases in MMSE, while increases in diastolic BP were linked to later improvements in MMSE (P < .05).”
Humans5 yearsn = 429
Age and ageing
Diastolic blood pressure is associated with cognitive function in humans (UK Biobank participants) (p < 0.0001).
“Baseline DBP had significant relationships with fluid intelligence (p < 0.0001) and attention (p < 0.0001), again with varying ideal DBPs (57.5 and 74.5 mmHg, respectively).”
HumansUK Biobank participantsn = 439,301
Does Ideal Blood Pressure Vary by Cognitive Domain? A UK Biobank Study
Journal of clinical hypertension (Greenwich, Conn.)
Diastolic blood pressure is associated with cognitive function in older adults with both hypertension and dyslipidemia (β = 0.08, P < 0.05).
“high diastolic BP (DBP) also resulted in higher MoCA-J scores (β = 0.08; P < 0.05)”
Humansin older adults with both hypertension and dyslipidemia3-year follow-up
Hypertension research : official journal of the Japanese Society of Hypertension
Diastolic blood pressure is associated with cognitive function in humans (individuals with SBP <120 only) (ß: 0.56, 95% CI: 0.09, 1.03).
“each 5 mmHg increment of DBP was associated with significantly higher DSST scores among individuals with SBP <120 only (ß: 0.56, 95% CI: 0.09, 1.03)”
Humansindividuals with SBP <120 onlyeach 5 mmHg increment of DBP
American journal of Alzheimer's disease and other dementias
Diastolic blood pressure is associated with cognitive function in humans (multivariate linear regression) (Exp(B) 0.041, 95% CI 0.002-0.079, P < 0.05).
“diastolic pressure [Exp(B): 0.041, 95% CI: 0.002-0.079] were positively associated with ARCF (P < 0.05).”
Humansmultivariate linear regression
Journal of inflammation research
Dementia
upin humans3downin silico1OR 0.765
4 studies
Dementia
upin humans3downin silico1OR 0.765
Diastolic blood pressure raises the risk of dementia in humans (participants with stroke or transient ischemic attack) (RR 1.23, 95% CI 1.12-1.36).
“while load showed the strongest association (1.23, 95% CI 1.12-1.36)”
Human trialparticipants with stroke or transient ischemic attack4 (median) yearsn = 5,128
American journal of hypertension
Diastolic blood pressure is linked with a higher risk of dementia in humans (DBP < 80 mmHg vs 80-89 mmHg).
“participants in the DBP < 80 mmHg subgroup and the DBP ≥100 mmHg subgroup had OR for dementia of 1.611 (95% CI: 1. 252-2.073, P < 0.001)”
HumansDBP < 80 mmHg vs 80-89 mmHgn = 3,599
Association between blood pressure and dementia in older adults: a cross-sectional study from China
Frontiers in aging neuroscience
Diastolic blood pressure is linked with a higher risk of dementia in humans (low-stable DBP trajectory vs normal-stable) (HR 1.58, P<0.005).
“low (HR: 1.58) and moderate-low stable (HR: 1.56) DBP trajectories increased dementia risk (both P<0.005).”
Humanslow-stable DBP trajectory vs normal-stableup to 10 yearsn = 7,566
The journal of prevention of Alzheimer's disease
Diastolic blood pressure lowers the risk of dementia in silico (OR = 0.765; 95% CI: 0.617-0.949).
“diastolic blood pressure showed a statistically significant inverse association with dementia risk (OR = 0.765; 95% CI: 0.617-0.949; P = 0.015).”
In silico
BMC neurology
Age
no changein humans1upin humans1downin humans1
3 studies
Age
no changein humans1upin humans1downin humans1
Age is associated with diastolic blood pressure in humans (Posbindu clients in Marawola District) (r=-0.005).
“Age had a significant positive correlation with systolic blood pressure (r=0.221; p<0.001), but was not correlated with diastolic blood pressure (r=-0.005; p=0.915).”
HumansPosbindu clients in Marawola Districtn = 406
Correlation Between Client Characteristics and Blood Pressure in Marawola District
JURNAL KESEHATAN PERINTIS (Perintis s Health Journal)
Age is associated with diastolic blood pressure in humans (β = 0.1485, R2 = 0.0409).
“Diastolic BP = 0.1485, R2= 0.0409”
Humans
Nigerian Journal of Basic and Clinical Sciences.
Age is associated with diastolic blood pressure in chronic hemodialyzed patients (standardized beta: -0.407, p < 0.001).
“DBP values, tPA, phosphorus, and D-dimer levels were independently associated with the age of patients (standardized betas: -0.407, 0.272, -0.230, and 0.197, respectively; p < 0.001 for all)”
Humansin chronic hemodialyzed patientsn = 289
Age-Related Changes in Clinical and Analytical Variables in Chronic Hemodialyzed Patients
International journal of molecular sciences
10-year cardiovascular risk
upin humans2
2 studies
10-year cardiovascular risk
upin humans2
Diastolic blood pressure is associated with 10-year cardiovascular risk in humans (both hypertensive and non-hypertensive patients).
“Diastolic blood pressure was positively associated with cardiovascular risk among both hypertensive and non-hypertensive patients.”
Humansboth hypertensive and non-hypertensive patients
Research SquarePreprint
Diastolic blood pressure is associated with 10-year cardiovascular risk in humans (Both hypertensive and non-hypertensive patients).
“DBP showed a positive correlation with cardiovascular risk in both hypertensive and non-hypertensive groups.”
HumansBoth hypertensive and non-hypertensive patientsn = 714
Research SquarePreprint
Stroke
upin humans2HR 2.32
2 studies
Stroke
upin humans2HR 2.32
Diastolic blood pressure is associated with stroke in humans (newly diagnosed hypertension) (Adjusted HR 2.32, 95% credible interval 1.35–4.27).
“Higher current underlying systolic and diastolic blood pressure levels were associated with increased stroke risk”
Humansnewly diagnosed hypertensionn = 494
PloS one
Diastolic blood pressure is associated with stroke in treatment-eligible hypertensive patients.
“Diabetes and DBP had stronger associations with stroke compared to ACS and heart failure.”
Humansin treatment-eligible hypertensive patients10-yearn = 12,238
Journal of hypertension
Fine particulate matter
upin humans2
2 studies
Fine particulate matter
upin humans2
Fine particulate matter is associated with diastolic blood pressure in humans.
“PM2.5 was positively associated with diastolic blood pressure and non-linearly associated with systolic blood pressure”
Humansn = 4,141
Toxics
Fine particulate matter is associated with diastolic blood pressure in humans (Cancer survivors with low physical activity) (β = 0.60, 95% CI = 0.21, 0.99).
“The associations of PM and CO with higher diastolic blood pressure (DBP) were observed in the low PA group”
HumansCancer survivors with low physical activitythree-year average exposures
Scientific reports
Body mass index
upin humans2
2 studies
Body mass index
upin humans2
Body mass index predicts diastolic blood pressure in humans (multivariable linear regression) (β=+1.20; p=0.004).
“BMI was the main independent predictor of DBP (β=+1.20; p=0.004).”
Humansmultivariable linear regressionn = 71
Bulletin of Science and Practice
Body mass index is associated with diastolic blood pressure in humans (Posbindu clients in Marawola District) (r=0.188).
“IMT was not significantly correlated with systolic blood pressure (r=0.075; p=0.131), but had a significant positive correlation with diastolic blood pressure (r=0.188; p<0.001).”
HumansPosbindu clients in Marawola Districtn = 406
Correlation Between Client Characteristics and Blood Pressure in Marawola District
JURNAL KESEHATAN PERINTIS (Perintis s Health Journal)
Air pollution
upin humans2
2 studies
Air pollution
upin humans2
Air pollution is associated with diastolic blood pressure in humans (cumulative lag models).
“PM2.5, PM10, SO2 with increased DBP”
Humanscumulative lag models
Research SquarePreprint
Air pollution is associated with diastolic blood pressure in humans (0.38 mmHg (95% CI: − 0.18 to 0.94)).
“0.38 mmHg rise in DBP (95% CI: − 0.18 to 0.94)”
Review10 μg/m3 increase
BMC public health
Polygenic risk score
upin humans2
2 studies
Polygenic risk score
upin humans2
Polygenic risk score predicts diastolic blood pressure in individuals with systemic arterial hypertension (r = 0.84).
“The resulting PRSs showed strong correlations with both ΔSBP (r = 0.85; p < 0.0001) and ΔDBP (r = 0.84; p < 0.0001).”
Human trialin individuals with systemic arterial hypertension180 days
European journal of nutrition
Polygenic risk score predicts diastolic blood pressure in humans (incremental R2 +1.4%, p = 0.012).
“1.4% for DBP (p = 0.012), and 1.1% for mean arterial pressure (MAP) (p = 0.044)”
Humans
Pathway-specific polygenic risk scores for blood pressure traits in a West African cohort
Frontiers in cardiovascular medicine
Hybrid CNN-Bi-LSTM-attention network
upin humans1
1 study
Hybrid CNN-Bi-LSTM-attention network
upin humans1
hybrid CNN-Bi-LSTM-attention network predicts diastolic blood pressure in humans (leave-one-subject-out evaluation) (MAE 3.21 mmHg, r = 0.946).
“the proposed model achieved mean absolute errors of 3.21 mmHg for diastolic BP and 4.12 mmHg for systolic BP, with correlation coefficients of 0.946 and 0.918”
Human trialleave-one-subject-out evaluationn = 10
Sensor Review
ACE
downin humans1
1 study
ACE
downin humans1
ACE is associated with diastolic blood pressure in Valsartan/HCTZ-treated hypertensive patients (13.7 mmHg vs 8.0 mmHg (p = 0.017)).
“ACE I/D significantly affected DBP, with II carriers achieving 13.7 mmHg versus 8.0 mmHg in DD (p = 0.017).”
Human trialin Valsartan/HCTZ-treated hypertensive patients4-week
Pharmacogenetics of RAS-affecting AGT and ACE variants and the efficacy of Valsartan/HCTZ therapy
Scientific reports
Resting systolic blood pressure
upin humans1
1 study
Resting systolic blood pressure
upin humans1
Resting systolic blood pressure predicts diastolic blood pressure in humans during post-exercise muscle ischemia (β = 0.412, p = 0.047).
“resting SBP was a significant independent determinant of DBP response to the rhythmic handgrip exercise during PEMI (β = 0.412, p = 0.047)”
Human trialduring post-exercise muscle ischemia
Physiological reports
Serum magnesium
downin humans1
1 study
Serum magnesium
downin humans1
Serum magnesium is associated with diastolic blood pressure in humans.
“serum Mg was negatively associated with diastolic BP but not systolic BP (all P<0.05)”
Human trialn = 2,028
Hypertension (Dallas, Tex. : 1979)
All 147Fewer
Funding
1 grant since 2024Wellcome Trust